CRTX — CRISM' Therapeutics Share News
0.000.00%
Last trade - 00:00- £4.30m
- £2.43m
REG - CRISM Therapeutics - Result of Retail Offer and Additional Placing
AnnouncementRCS - CRISM Therapeutics - Update presentation on the IMC platform
AnnouncementREG - CRISM Therapeutics - Submission of CTA Application
AnnouncementREG - CRISM Therapeutics - Retail Offer
AnnouncementREG - CRISM Therapeutics - Placing
AnnouncementREG - CRISM Therapeutics - Final Results for the year ended 31 December 2024
AnnouncementRCS - CRISM Therapeutics - Best Paper Award
AnnouncementREG - CRISM Therapeutics - Establishment of Scientific Advisory Board
AnnouncementREG - CRISM Therapeutics - Director Dealing
AnnouncementREG - CRISM Therapeutics - Clinical Trial Update
AnnouncementREG - CRISM Therapeutics - Innovate UK Grant Award
AnnouncementREG - CRISM Therapeutics - Appointment of Specialist Clinical CRO
AnnouncementREG - CRISM Therapeutics - European Patent Grant
AnnouncementREG - CRISM Therapeutics - Interim Results
AnnouncementREG - CRISM Therapeutics - Notice of Interim Results & IMC Presentation
AnnouncementRCS - CRISM Therapeutics - Delivery Method Validated in Peer Reviewed Journal
AnnouncementREG - CRISM Therapeutics - Innovation Passport Award
AnnouncementREG - Crism Therapeutics - CRISM Signs Service Agreement Contract
AnnouncementREG - Crism Therapeutics - Response to Movement in Share Price
Announcement